Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bacticide is a topical antiseptic and disinfectant solution developed and manufactured by Euro-Med Laboratories Philippines, Inc. It is primarily indicated for the disinfection of wounds, burns, lacerations, and abrasions, as well as for pre- and post-operative skin preparation prior to injections or surgical procedures. The product is registered with the Philippines Food and Drug Administration (FDA) and is part of Euro-Med's commercial portfolio of sterile pharmaceutical solutions. As a biocide, it functions by eliminating or inhibiting the growth of a broad spectrum of microorganisms on the skin's surface to prevent or treat local infections. The formulation is typically available as a 10% povidone-iodine solution, which is a well-established antiseptic agent known for its efficacy against bacteria, viruses, and fungi.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bacticide.